5:59 PM
 | 
Oct 25, 2012
 |  BC Extra  |  Financial News

Orexigen adds $60.5 million

Orexigen Therapeutics Inc. (NASDAQ:OREX) raised $60.5 million through the sale of 11 million shares at $5.50 in follow-on underwritten by Credit Suisse; BofA Merrill Lynch; and Leerink. Orexigen...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >